Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C24H30N2O2S |
| Molecular Weight | 410.572 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)C1=CC=C2SC3=CC=CC=C3N(CCCN4CCC(CCO)CC4)C2=C1
InChI
InChIKey=BTFMCMVEUCGQDX-UHFFFAOYSA-N
InChI=1S/C24H30N2O2S/c1-18(28)20-7-8-24-22(17-20)26(21-5-2-3-6-23(21)29-24)13-4-12-25-14-9-19(10-15-25)11-16-27/h2-3,5-8,17,19,27H,4,9-16H2,1H3
| Molecular Formula | C24H30N2O2S |
| Molecular Weight | 410.572 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Piperacetazine (Quide) is an antipsychotic prodrug, most notably used for schizophrenia. The study indicates that Quide is a useful addition to the armamentarium of the physician faced with the difficult problem of treating the chronic hospitalized patient with a schizophrenic illness. Side effects of the drug were generally mild, and there was no evidence that it would produce blood dyscrasias or liver impairment.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:45:19 GMT 2025
by
admin
on
Mon Mar 31 17:45:19 GMT 2025
|
| Record UNII |
KL6248WNW4
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C740
Created by
admin on Mon Mar 31 17:45:19 GMT 2025 , Edited by admin on Mon Mar 31 17:45:19 GMT 2025
|
||
|
NCI_THESAURUS |
C29710
Created by
admin on Mon Mar 31 17:45:19 GMT 2025 , Edited by admin on Mon Mar 31 17:45:19 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C067601
Created by
admin on Mon Mar 31 17:45:19 GMT 2025 , Edited by admin on Mon Mar 31 17:45:19 GMT 2025
|
PRIMARY | |||
|
SUB09866MIG
Created by
admin on Mon Mar 31 17:45:19 GMT 2025 , Edited by admin on Mon Mar 31 17:45:19 GMT 2025
|
PRIMARY | |||
|
223-312-0
Created by
admin on Mon Mar 31 17:45:19 GMT 2025 , Edited by admin on Mon Mar 31 17:45:19 GMT 2025
|
PRIMARY | |||
|
8338
Created by
admin on Mon Mar 31 17:45:19 GMT 2025 , Edited by admin on Mon Mar 31 17:45:19 GMT 2025
|
PRIMARY | RxNorm | ||
|
DTXSID7023481
Created by
admin on Mon Mar 31 17:45:19 GMT 2025 , Edited by admin on Mon Mar 31 17:45:19 GMT 2025
|
PRIMARY | |||
|
760067
Created by
admin on Mon Mar 31 17:45:19 GMT 2025 , Edited by admin on Mon Mar 31 17:45:19 GMT 2025
|
PRIMARY | |||
|
CHEMBL1584
Created by
admin on Mon Mar 31 17:45:19 GMT 2025 , Edited by admin on Mon Mar 31 17:45:19 GMT 2025
|
PRIMARY | |||
|
1014
Created by
admin on Mon Mar 31 17:45:19 GMT 2025 , Edited by admin on Mon Mar 31 17:45:19 GMT 2025
|
PRIMARY | |||
|
KL6248WNW4
Created by
admin on Mon Mar 31 17:45:19 GMT 2025 , Edited by admin on Mon Mar 31 17:45:19 GMT 2025
|
PRIMARY | |||
|
C66396
Created by
admin on Mon Mar 31 17:45:19 GMT 2025 , Edited by admin on Mon Mar 31 17:45:19 GMT 2025
|
PRIMARY | |||
|
3819-00-9
Created by
admin on Mon Mar 31 17:45:19 GMT 2025 , Edited by admin on Mon Mar 31 17:45:19 GMT 2025
|
PRIMARY | |||
|
2186
Created by
admin on Mon Mar 31 17:45:19 GMT 2025 , Edited by admin on Mon Mar 31 17:45:19 GMT 2025
|
PRIMARY | |||
|
m8844
Created by
admin on Mon Mar 31 17:45:19 GMT 2025 , Edited by admin on Mon Mar 31 17:45:19 GMT 2025
|
PRIMARY | Merck Index | ||
|
19675
Created by
admin on Mon Mar 31 17:45:19 GMT 2025 , Edited by admin on Mon Mar 31 17:45:19 GMT 2025
|
PRIMARY | |||
|
100000081964
Created by
admin on Mon Mar 31 17:45:19 GMT 2025 , Edited by admin on Mon Mar 31 17:45:19 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |